Genes & Development · 2017 · 79 citations · 33 references
MedicineMolecular BiologyOncologyCell SignalingGene ExpressionMolecular OncologyCancer Cell SignalingCancer EpigeneticsEpigenetic Regulation In CancerMetabolic ReprogrammingMetabolic Reprogramming In CancerSignal Transduction In CancerAdiponectin SignalingCancer Signaling PathwaysCompass ComplexHistone MethyltransferasesHistone-lysine MethylationOmega-3 Fatty Acid MetabolismTherapeutic ModulationTumor Cell Survival Pathways
Mutations and translocations within the COMPASS (complex of proteins associated with Set1) family of histone lysine methyltransferases are associated with a large number of human diseases, including cancer. Here we report that SET1B/COMPASS, which is essential for cell survival, surprisingly has a cytoplasmic variant. SET1B, but not its SET domain, is critical for maintaining cell viability, indicating a novel catalytic-independent role of SET1B/COMPASS. Loss of SET1B or its unique cytoplasmic-interacting protein, BOD1, leads to up-regulation of expression of numerous genes modulating fatty acid metabolism, including ADIPOR1 ( adiponectin receptor 1 ) , COX7C , SDC4 , and COQ7 . Our detailed molecular studies identify ADIPOR1 signaling, which is inactivated in both obesity and human cancers, as a key target of SET1B/COMPASS. Collectively, our study reveals a cytoplasmic function for a member of the COMPASS family, which could be harnessed for therapeutic regulation of signaling in human diseases, including cancer.
33
TopHat: discovering splice junctions with RNA-Seq
Cole Trapnell, Lior Pachter, Steven L. Salzberg · Bioinformatics · 2009 · 12.1K citations · Full text